Short-term immunotherapy: A prospective, randomized, double-blind, placebo-controlled multicenter study of molecular standardized grass and rye allergens in patients with grass pollen-induced allergic rhinitis

被引:57
作者
Zenner, HP
Baumgarten, C
Rasp, G
Fuchs, T
Kunkel, G
Hauswald, B
Ring, J
Effendy, I
Behrendt, W
Frosch, PJ
Przybilla, B
Brunner, FX
Merk, HF
Kapp, A
Schnitker, J
Wolf, H
机构
[1] SCHERAX ARZNEIMITTEL GMBH,D-22589 HAMBURG,GERMANY
[2] UNIV TUBINGEN,HNO KLIN,TUBINGEN,GERMANY
[3] FREE UNIV BERLIN,KLINIKUM RUDOLF VIRCHOW,ABT KLIN IMMUNOL & ASTHMAPOLIKLIN,D-1000 BERLIN,GERMANY
[4] MAXIMILIANS UNIV,KLINIKUM GROSSHADERN,HNO KLIN & POLIKLIN,MUNICH,GERMANY
[5] UNIV GOTTINGEN,HAUTKLIN,D-3400 GOTTINGEN,GERMANY
[6] MED ACAD CARL GUSTAV CARUS,HNO KLIN,DRESDEN,GERMANY
[7] TECH UNIV MUNICH,DERMATOL KLIN & POLIKLIN,D-8000 MUNICH,GERMANY
[8] KLINIKUM PHILIPPS UNIV,MED ZENTRUM HAUTKRANKHEITEN,MARBURG,GERMANY
[9] UNIV LEIPZIG,HNO KLIN,D-7010 LEIPZIG,GERMANY
[10] UNIV WITTEN HERDECKE,WITTEN,GERMANY
[11] STADT KLINIKEN,HAUTKLIN,DORTMUND,GERMANY
[12] UNIV MUNICH,DERMATOL KLIN & POLIKLIN,D-80539 MUNICH,GERMANY
[13] UNIV WURZBURG,HNO KLIN & POLIKLIN,WURZBURG,GERMANY
[14] RHEIN WESTFAL TH AACHEN,HAUTKLIN,D-5100 AACHEN,GERMANY
[15] HANNOVER MED SCH,DERMATOL KLIN & POLIKLIN,HANNOVER,GERMANY
[16] INST ANGEW STAT,BIELEFELD,GERMANY
关键词
short-term immunotherapy; specific immunotherapy; allergic rhinitis; grass pollen; rye pollen; skin prick rest; specific IgE; specific IgG4;
D O I
10.1016/S0091-6749(97)70190-8
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Background: Short-term immunotherapy (STI) can be beneficial for patients who are noncompliant,vith long-term specific immunotherapy. Objective: The efficacy and tolerance of STI with seven pre-seasonal injections of molecular standardized allergens from grass and rye pollen has been investigated in a double-blind, placebo-controlled multicenter study with 87 patients at 12 German University hospitals. Methods: Symptoms of the eyes, nose, and bronchi and use of symptomatic drugs were documented daily in diaries by patients with allergic rhinitis to grass and/or rye pollen and without bronchial asthma. Patients were monitored by skin prick test titration and measurement of levels of specific IgE and IgG4. Results: The median nasal score for the 10 weeks with the strongest symptoms during the gross pollen season was significantly lower (p = 0.014) with 35.0 for STI (n = 41) versus 69.0 for placebo (n = 40); the overall symptom score was 54.0 for STI versus 97.5 for placebo (p = 0.020). Only STI-treated patients exposed to less than 40 pollen grains per cubic meter per week showed a significantly lower nasal symptom score of 39.0 versus 75.0 for placebo (p = 0.006); these patients also had fewer nasal symptoms and less use of topical nasal drugs (p < 0.001). The threshold dose in skin prick tests was significantly higher, being 9.06 histamine equivalent for skin prick test (HEP) for STI-treated patients who received the maximum dose (n = 22) versus 4.33 HEP for placebo (p = 0.005). Specific IgE levels were significantly higher, being 55.9 SU/ml for STI versus 393 SU/ml for placebo after seven injections (p = 0.006) and level of specific IgG4 was 5.36% for STI versus 1.28% for placebo (p < 0.001). No severe systemic reactions were observed. Conclusion: Sn with seven preseasonal injections with molecular standardized allergens is effective and well tolerated.
引用
收藏
页码:23 / 29
页数:7
相关论文
共 23 条
[1]   STANDARDIZATION OF ALLERGEN EXTRACTS WITH APPROPRIATE METHODS - COMBINED USE OF SKIN PRICK TESTING AND RADIO-ALLERGOSORBENT TESTS [J].
AAS, K ;
BACKMAN, A ;
BELIN, L ;
WEEKE, B .
ALLERGY, 1978, 33 (03) :130-137
[2]   EVALUATION OF IMMUNOTHERAPY-INDUCED CHANGES IN SPECIFIC IGE, IGG AND IGG SUBCLASSES IN BIRCH POLLEN ALLERGIC PATIENTS BY MEANS OF IMMUNOBLOTTING - CORRELATION WITH CLINICAL-RESPONSE [J].
BIRKNER, T ;
RUMPOLD, H ;
JAROLIM, E ;
EBNER, H ;
BREITENBACH, M ;
SKVARIL, F ;
SCHEINER, O ;
KRAFT, D .
ALLERGY, 1990, 45 (06) :418-426
[3]   ALLERGIC RHINITIS TO RAGWEED POLLEN .2. MODULATION OF HISTAMINE-RELEASING FACTOR PRODUCTION BY SPECIFIC IMMUNOTHERAPY [J].
BRUNET, C ;
BEDARD, PM ;
LAVOIE, A ;
JOBIN, M ;
HEBERT, J .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1992, 89 (01) :87-94
[5]  
EEC Note for Guidance: Good Clinical Practice for Trials on Medicinal Products in the European Community, 1990, PHARMACOL TOXICOL, V67, P361
[6]   SUPPRESSION OF THE LATE CUTANEOUS RESPONSE BY IMMUNOTHERAPY [J].
FLING, JA ;
RUFF, ME ;
PARKER, WA ;
WHISMAN, BA ;
MARTIN, ME ;
MOSS, RB ;
REID, MJ .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1989, 83 (01) :101-109
[7]   THE INTERNATIONAL COLLABORATIVE STUDY ESTABLISHING THE 1ST INTERNATIONAL STANDARD FOR TIMOTHY (PHLEUM-PRATENSE) GRASS-POLLEN ALLERGENIC EXTRACT [J].
GJESING, B ;
JAGER, L ;
MARSH, DG ;
LOWENSTEIN, H .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1985, 75 (02) :258-267
[8]   A CONTROLLED DOSE-RESPONSE STUDY OF IMMUNOTHERAPY WITH STANDARDIZED, PARTIALLY PURIFIED EXTRACT OF HOUSE DUST MITE - CLINICAL EFFICACY AND SIDE-EFFECTS [J].
HAUGAARD, L ;
DAHL, R ;
JACOBSEN, L .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1993, 91 (03) :709-722
[9]   COMPARISON OF THE INVIVO AND INVITRO RESPONSE TO RAGWEED IMMUNOTHERAPY IN CHILDREN AND ADULTS WITH RAGWEED-INDUCED RHINITIS [J].
HEDLIN, G ;
SILBER, G ;
NACLERIO, R ;
PROUD, D ;
LAMAS, AM ;
EGGLESTON, P ;
ADKINSON, NF .
CLINICAL AND EXPERIMENTAL ALLERGY, 1990, 20 (05) :491-500
[10]   PROCEDURES FOR 2-SAMPLE COMPARISONS WITH MULTIPLE END-POINTS CONTROLLING THE EXPERIMENTWISE ERROR RATE [J].
LEHMACHER, W ;
WASSMER, G ;
REITMEIR, P .
BIOMETRICS, 1991, 47 (02) :511-521